Settlement Agreements in the Biotechnology Industry
195 Contracts & Agreements
- ABEONA THERAPEUTICS INC. (1 contract)
- Adhera Therapeutics, Inc. (2)
- Advaxis, Inc. (2)
- Aimmune Therapeutics, Inc. (1)
- Alexion Pharmaceuticals (3)
- Alkermes plc. (1)
- Allarity Therapeutics, Inc. (1)
- Allogene Therapeutics, Inc. (1)
- ALNYLAM PHARMACEUTICALS, INC. (1)
- AMARILLO BIOSCIENCES INC (1)
- ANAPTYSBIO INC (1)
- Anika Therapeutics (1)
- Anixa Biosciences Inc (1)
- Arbutus Biopharma Corp (1)
- ARENA PHARMACEUTICALS INC (1)
- Arsanis, Inc. (1)
- ATHERSYS, INC (1)
- Aurinia Pharmaceuticals Inc. (1)
- AVEO PHARMACEUTICALS INC (1)
- Avid Bioservices, Inc. (1)
- AZIYO BIOLOGICS, INC. (1)
- AzurRx BioPharma, Inc. (2)
- BICYCLE THERAPEUTICS Ltd (2)
- BioCardia, Inc. (1)
- Biogen Inc. (1)
- BIOMARIN PHARMACEUTICAL INC (3)
- BIOSPECIFICS TECHNOLOGIES CORP (1)
- BIOTIME INC (1)
- Blue Water Vaccines Inc. (1)
- BRAINSTORM CELL THERAPEUTICS INC. (1)
- Calyxt, Inc. (1)
- CANCER GENETICS, INC (2)
- CATALYST PHARMACEUTICALS, INC. (2)
- Celldex Therapeutics, Inc. (2)
- Celsion CORP (2)
- Chanticleer Holdings, Inc. (1)
- CLEVELAND BIOLABS INC (1)
- Coherus BioSciences, Inc. (2)
- Comera Life Sciences Holdings, Inc. (1)
- CTI BIOPHARMA CORP (2)
- Curative Biotechnology Inc (3)
- Cyclacel Pharmaceuticals, Inc. (3)
- CytoDyn Inc. (1)
- CYTORI THERAPEUTICS, INC. (1)
- DelMar Pharmaceuticals, Inc. (1)
- Dicerna Pharmaceuticals Inc (1)
- Diffusion Pharmaceuticals Inc. (3)
- Eagle Pharmaceuticals, Inc. (4)
- Eliem Therapeutics, Inc. (1)
- ENDONOVO THERAPEUTICS, INC. (1)
- Esperion Therapeutics, Inc. (1)
- Forty Seven, Inc. (1)
- GENEREX BIOTECHNOLOGY CORP (4)
- GT Biopharma, Inc. (5)
- HCW Biologics Inc. (1)
- HedgePath Pharmaceuticals, Inc. (1)
- HUMANIGEN, INC (1)
- iBio, Inc. (2)
- Immune Therapeutics, Inc. (7)
- IMMUNOMEDICS INC (1)
- INFINITY PHARMACEUTICALS, INC. (1)
- Inhibikase Therapeutics, Inc. (1)
- Innovation Pharmaceuticals Inc. (1)
- International Stem Cell CORP (1)
- IOVANCE BIOTHERAPEUTICS, INC. (1)
- KBL MERGER CORP. IV (3)
- Kiromic Biopharma, Inc. (2)
- Leisure Acquisition Corp. (1)
- Ligand Pharmaceuticals Incorporated (1)
- MANNKIND CORP (1)
- Merus N.V. (2)
- MiMedx Group, Inc. (1)
- Minerva Neurosciences, Inc. (1)
- Momenta Pharmaceuticals, Inc. (1)
- NANOVIRICIDES, INC. (2)
- NantKwest, Inc. (1)
- NAVIDEA BIOPHARMACEUTICALS, INC. (2)
- NEWLINK GENETICS CORP (1)
- NORTHWEST BIOTHERAPEUTICS INC (2)
- NOVAVAX INC (3)
- Nuo Therapeutics, Inc. (2)
- Opko Health, Inc. (2)
- Orchard Therapeutics plc (1)
- ORGANOVO HOLDINGS, INC. (1)
- Pasithea Therapeutics Corp. (1)
- PDL BIOPHARMA, INC. (3)
- PharmaCyte Biotech, Inc. (1)
- PhaseBio Pharmaceuticals Inc (1)
- PIERIS PHARMACEUTICALS, INC. (1)
- POLARITYTE, INC. (1)
- Progenics Pharmaceuticals, Inc. (2)
- PROGENITY, INC. (15)
- Propanc Biopharma, Inc. (3)
- PROTEOSTASIS THERAPEUTICS, INC. (2)
- ProtoKinetix, Inc. (1)
- Regeneron Pharmaceuticals (2)
- REGENXBIO Inc. (1)
- Retrophin, Inc. (1)
- RITTER PHARMACEUTICALS INC (1)
- Sarepta Therapeutics, Inc. (1)
- Savara Inc (1)
- SELLAS Life Sciences Group, Inc. (3)
- SPHERIX INC (3)
- Syndax Pharmaceuticals Inc (1)
- TENAX THERAPEUTICS, INC. (1)
- TG THERAPEUTICS, INC. (1)
- Twist Bioscience Corp (1)
- United Therapeutics Corp (2)
- Vanda Pharmaceuticals Inc. (1)
- Vaxart, Inc. (2)
- VICAL INC (1)
- VITAL THERAPIES INC (1)
- VITRO DIAGNOSTICS INC (2)
- Xenetic Biosciences, Inc. (2)
- XOMA Corp (2)
- Y-mAbs Therapeutics, Inc. (1)
- YIELD10 BIOSCIENCE, INC. (1)
- Settlement and Release Agreement, dated as of January 2, 2025, by and between the Company and Paul McBarron (Cyclacel Pharmaceuticals, Inc., Filed With SEC on January 6, 2025)
- Settlement and Release Agreement, dated as of January 2, 2025, by and between the Company and Spiro Rombotis (Cyclacel Pharmaceuticals, Inc., Filed With SEC on January 6, 2025)
- Form of Director Settlement Agreement and Release (Cyclacel Pharmaceuticals, Inc., Filed With SEC on January 6, 2025)
- Settlement Agreement and Release, dated July 13, 2024, by and between the Company and Altor BioScience, LLC, NantCell, Inc., and ImmunityBio, Inc (HCW Biologics Inc., Filed With SEC on November 14, 2024)
- Settlement Agreement and Release dated July 13, 2024 entered into by and among Altor BioScience, LLC, NantCell, Inc., HCW Biologics, Inc., and Dr. Hing C. Wong (NantKwest, Inc., Filed With SEC on November 12, 2024)
- Settlement Agreement, dated as of September 13, 2024, by and between Kineta, Inc. and ARE-SEATTLE No.17, LLC (PROTEOSTASIS THERAPEUTICS, INC., Filed With SEC on November 6, 2024)
- Settlement Agreement, dated as of September 30, 2024 (Inhibikase Therapeutics, Inc., Filed With SEC on October 10, 2024)
- Settlement Agreement, dated August 23, 2024, between Eliem Therapeutics, Inc. and Valerie Morisset, Ph.D (Eliem Therapeutics, Inc., Filed With SEC on August 27, 2024)
- Amendment and Settlement Agreement, dated May 10, 2024, by and between Les Laboratoires Servier, Institut de Recherches Internationales Servier and Allogene Therapeutics, Inc (Allogene Therapeutics, Inc., Filed With SEC on August 7, 2024)
- Settlement Agreement and Mutual Release, dated May 17, 2024, by and among Woodforest National Bank, iBio CDMO LLC and the Company (iBio, Inc., Filed With SEC on May 20, 2024)
- Confidential Settlement Agreement and General Release (James G. Cullem) (Allarity Therapeutics, Inc., Filed With SEC on May 14, 2024)
- Confidential Settlement Agreement and Release, dated March 21, 2024, between the Company and FUJIFILM Diosynth Biotechnologies UK Limited, FUJIFILM Diosynth Biotechnologies Texas,... (NOVAVAX INC, Filed With SEC on May 10, 2024)
- Confidential Settlement Agreement and Release, dated as of January 2, 2024, between the Registrant and Daiichi Sankyo Europe GmbH (Esperion Therapeutics, Inc., Filed With SEC on May 7, 2024)
- Amendment No. 1 to Settlement and Investment Agreement, dated as of April 25, 2024, by and between GT Biopharma, Inc. and Cytovance Biologics, Inc (GT Biopharma, Inc., Filed With SEC on April 30, 2024)
- Settlement Agreement and Mutual Release, dated as of April 22, 2024, by and between Kineta, Inc. and RLB Holdings, Connecticut, LLC (PROTEOSTASIS THERAPEUTICS, INC., Filed With SEC on April 24, 2024)
- Settlement Agreement between Immune Therapeutics, Inc. and Jack Brewer dated October 23, 2022 (Immune Therapeutics, Inc., Filed With SEC on April 16, 2024)
- Plan Support and Settlement Agreement, dated as of March 5, 2024, by and between PhaseBio Pharmaceuticals, Inc. and SFJ Pharmaceuticals X, Inc. (f/k/a SFJ Pharmaceuticals X, Ltd.) (PhaseBio Pharmaceuticals Inc, Filed With SEC on March 12, 2024)
- Mutual Release and Settlement Agreement, dated November 20, 2022, by and between the Registrant and Jack Zamora (VITRO DIAGNOSTICS INC, Filed With SEC on January 29, 2024)
- Settlement Agreement and General Release, dated August 8, 2023, between the Company and SK bioscience Co., Ltd (NOVAVAX INC, Filed With SEC on November 9, 2023)
- Settlement and License Agreement among Coherus BioSciences, Inc., AbbVie Inc. and AbbVie Biotechnology Ltd dated January 24, 2019 (Coherus BioSciences, Inc., Filed With SEC on November 6, 2023)
- Confidential Settlement and License Agreement, dated August 29, 2023, by and among Alkermes, Inc., Alkermes Pharma Ireland Limited and Teva Pharmaceuticals USA, Inc (Alkermes plc., Filed With SEC on October 25, 2023)
- Forbearance, Restructuring and Settlement Agreement, dated as of May 17, 2023, between Athersys, Inc., certain subsidiaries of Athersys, Inc., and (ATHERSYS, INC, Filed With SEC on August 16, 2023)
- Amendment and Settlement Agreement, dated July 20, 2023, by and between Qualigen Therapeutics, Inc. and Nanosynex Ltd (RITTER PHARMACEUTICALS INC, Filed With SEC on July 26, 2023)
- Settlement Agreement between the Company and Statera Biopharma, Inc. dated April 12, 2023 (Immune Therapeutics, Inc., Filed With SEC on April 20, 2023)
- Settlement Agreement, by and between the Registrant, Teva Pharmaceuticals International GmbH, Cephalon, LLC, Dr. Reddys Laboratories, Ltd. and Dr. Reddys Laboratories, Inc., dated... (Eagle Pharmaceuticals, Inc., Filed With SEC on April 10, 2023)
- Settlement Agreement between Immune Therapeutics, Inc. and Jack Brewer dated October 23, 2022 (Immune Therapeutics, Inc., Filed With SEC on April 10, 2023)
- Settlement Agreement dated as of December 16, 2022, by and between the Registrant and Catalent Pharma Solutions, LLC (HUMANIGEN, INC, Filed With SEC on March 30, 2023)
- Stipulation and Agreement of Compromise and Settlement dated October 26, 2022 (BIOTIME INC, Filed With SEC on March 9, 2023)
- Mutual Release and Settlement Agreement, dated November 20, 2022, by and between the Registrant and Jack Zamora (VITRO DIAGNOSTICS INC, Filed With SEC on January 30, 2023)
- Stipulation and Agreement of Compromise, Settlement, and Release, dated September 9, 2022 (HedgePath Pharmaceuticals, Inc., Filed With SEC on December 19, 2022)
- Settlement and Cooperation Agreement dated December 9, 2022, by and between Pasithea Therapeutics Corp. and Camac Fund, LP and its affiliates (Pasithea Therapeutics Corp., Filed With SEC on December 14, 2022)
- Form of Settlement Agreement, by and between the Representative and the Company, dated November 30, 2022 (AzurRx BioPharma, Inc., Filed With SEC on December 2, 2022)
- Settlement Agreement and Release, dated October 9, 2022, by and between the Registrant and Boustead Securities, LLC (Blue Water Vaccines Inc., Filed With SEC on November 14, 2022)
- Settlement and License Agreement, by and between Teva Pharmaceuticals International GmbH (Eagle Pharmaceuticals, Inc., Filed With SEC on November 9, 2022)
- Settlement Agreement, dated September 30, 2022, between the Company and FUJIFILM Diosynth Biotechnologies UK Limited, FUJIFILM Diosynth Biotechnologies Texas, LLC, and FUJIFILM... (NOVAVAX INC, Filed With SEC on November 9, 2022)
- Settlement Agreement dated August 9, 2021 (Curative Biotechnology Inc, Filed With SEC on November 7, 2022)
- Amended Stipulation of Settlement and Mutual Release, dated October 27, 2022, by and among Kiromic Biopharma, Inc., Empery Asset Master, Ltd. and other parties (Kiromic Biopharma, Inc., Filed With SEC on November 2, 2022)
- Settlement and Investment Agreement dated August 24, 2022, by and between GT Biopharma, Inc. and Cytovance Biologics, Inc (GT Biopharma, Inc., Filed With SEC on October 31, 2022)
- Stipulation of Settlement and Mutual Release, dated October 10, 2022, by and among Kiromic Biopharma, Inc., Empery Asset Master, Ltd. and other parties (Kiromic Biopharma, Inc., Filed With SEC on October 14, 2022)
- Settlement Agreement dated August 9, 2021 (Curative Biotechnology Inc, Filed With SEC on September 9, 2022)
